Kin Man Au

13PUBLICATIONS
4CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)NanomaterialsAutoimmunityMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Nov 06, 2024
Intratumoral Injectable Redox-Responsive Immune Niche Improves the Abscopal Effect in Radiotherapy.

Kin Man Au, J Steven Swinnea, Andrew Z Wang

|Jun 11, 2024
Author Correction: An injectable subcutaneous colon-specific immune niche for the treatment of ulcerative colitis.

Kin Man Au, Justin E Wilson, Jenny P-Y Ting

|May 28, 2024
Correction to "Bespoke Pretargeted Nanoradioimmunotherapy for the Treatment of Non-Hodgkin Lymphoma".

Kin Man Au, Ashutosh Tripathy, Carolina Pe-I Lin

|May 27, 2024
Erratum: Addition and Correction to "High-Performance Concurrent Chemo-Immuno-Radiotherapy for the Treatment of Hematologic Cancer through Selective High-Affinity Ligand Antibody Mimic-Functionalized Doxorubicin-Encapsulated Nanoparticles".

Kin Man Au, Rod Balhorn, Monique C Balhorn

|May 27, 2024
Correction to Immune Checkpoint Ligand Bioengineered Schwann Cells as Antigen-Specific Therapy for Experimental Autoimmune Encephalomyelitis.

Kin Man Au, Roland Tisch, Andrew Wang

|May 14, 2024
Correction to "Improving Cancer Chemoradiotherapy Treatment by Dual Controlled Release of Wortmannin and Docetaxel in Polymeric Nanoparticles".

Kin Man Au, Yuanzeng Min, Xi Tian

Pageof 3

Frequent Collaborators

7 joint publications

Andrew Z Wang

3 joint publications

Steven I Park

2 joint publications

Seungpyo Hong

1 joint publications

Yuanzeng Min